INDICAL BIOSCIENCE GmbH, headquartered in Leipzig, develops and sells technologies and diagnostic solutions for veterinary medicine and provides research and development services in these fields. In the 2024 financial year the company reported revenue of EUR 16,409,384.40. The company is a 100% subsidiary of INDICAL HOLDING GmbH and is included in the consolidated financial statements of Fidelio Capital AB and the Vimian Group AB. The average number of employees during the year was 69, distributed among production/QC (30), R&D (9) and sales (11).
Produktion und Vertrieb von Technologien und diagnostischen Lösungen für die Veterinärmedizin sowie Forschungs- bzw. Entwicklungsleistungen in diesen Bereichen.
Converted using the official Destatis and Eurostat correspondence tables; ISIC Rev. 4 is the United Nations' international industry classification.
This summary was generated with the help of AI. See our Data Quality Notice. Report error?
Source: German Commercial Register (Handelsregister) Leipzig Local Court, HRB 12760 (as of 18 November 2026)
| Name | Type | City |
|---|---|---|
| Claudia Engemann | Geschäftsführer(in) | Markkleeberg |
| Stefano Santarelli | Geschäftsführer(in) | Küsnacht |
Source: German Commercial Register (Handelsregister) Leipzig Local Court, HRB 12760 (as of 18 November 2026)
| Date | Event Type | Event |
|---|---|---|
| 07.12.2023 | Business Purpose Update | Produktion und Vertrieb von Technologien und diagnostischen Lösungen für die Veterinärmedizin sowie Forschungs- bzw. Entwicklungsleistungen in diesen Bereichen. |
| 07.12.2023 | Gesellschaftsvertrag amended | Gesellschaftsvertrag |
| 06.04.2018 | Gesellschaftsvertrag amended | Gesellschaftsvertrag |
| Date | Type | Change | Total Capital |
|---|---|---|---|
| 29.06.2004 | Capital Increase | +12.900 € | 42.900 € |
| 23.04.2002 | Share Capital Set | — | 30.000 € |
Source: German Commercial Register (Handelsregister) Leipzig Local Court, HRB 12760 (as of 18 November 2026)
| Year | Revenue | Profit | Balance | Employees |
|---|---|---|---|---|
| 2025 | €17,907,550 | €1,467,018 | €14,310,841 | — |
| 2024 | €16,409,384 | €731,028 | €15,647,313 | 69 |
| 2023 | €18,208,756 | €1,396,426 | €16,330,304 | 64 |
| 2022 | €17,494,132 | €1,906,844 | €16,033,898 | 67 |
| 2021 | €23,035,352 | €6,498,844 | €15,501,137 | 63 |
| 2020 | €20,898,147 | €6,323,033 | €15,432,280 | 38 |
| 2019 | €11,725,373 | €1,858,377 | €8,969,008 | 38 |
| 2018 | €7,858,908 | €672,023 | €6,936,396 | 32 |
| 2017 | €5,623,070 | €934,252 | €6,887,675 | — |
| 2016 | €5,736,571 | €1,064,097 | €5,774,246 | — |
Source: German Company Register (Unternehmensregister) · Annual accounts
Sign in to download data
Source: German Commercial Register (Handelsregister) Leipzig Local Court, HRB 12760 (as of 18 November 2026)
Lallemand Biologicals GmbH
Wismar · Herstellung von Schädlingsbekämpfungs-, Pflanzenschutz- und Desinfektionsmitteln
Biochrom GmbH
Berlin · Herstellung von pharmazeutischen Spezialitäten und sonstigen pharmazeutischen Erzeugnissen
EvoLogics GmbH
Berlin · Herstellung von elektrischen Mess-, Kontroll-, Navigations- u. ä. Instrumenten und Vorrichtungen